Clinical Trials and Studies
Some clinical trials have suspended enrollment until further notice due to COVID-19 considerations.
Lung and Chest Tumors
- ALCHEMIST Chemo-IO Study: Treatment for Treatment for Non-Small Cell Lung Cancer
- An ALCHEMIST Treatment Trial: Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer
- Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
- Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial
- Pulmonary and Critical Care Registry
- Study of First Line Treatment and Maintenance in Non-Small Cell Lung Cancer
- Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
- TETON Study: Inhalation Treatment for IPF
- The ALCHEMIST Screening Trial: Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer
- The Study to Assess Efficacy and Safety of Adjuvant Osimertinib vs Placebo in Participants with EGFR Mutation with NSCLC
- Treatment Study for Patients with Newly Diagnosed Stage III Non-Small Cell Lung Cancer